Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026GlobeNewsWire • Thursday
Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic CardiomyopathyGlobeNewsWire • 10/23/26
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin's Biological Effects in Cardiovascular DiseaseGlobeNewsWire • 10/21/26
Lexicon Pharmaceuticals: Upgrading On Sotagliflozin HCM Data In Q1 '27 And MoreSeeking Alpha • 09/30/26
This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga • 09/28/26
Lexicon Pharmaceuticals, Inc. (LXRX) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeeking Alpha • 09/09/26
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor ConferencesGlobeNewsWire • 09/01/26
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart FailureGlobeNewsWire • 08/31/26
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851GlobeNewsWire • 08/24/26
Lexicon Pharmaceuticals Edging Closer To 'Go Time' On Multiple Late-Stage AssetsSeeking Alpha • 08/19/26
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/06/26
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical UpdatesGlobeNewsWire • 08/06/26
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026GlobeNewsWire • 07/30/26
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)GlobeNewsWire • 07/27/26
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?The Motley Fool • 06/11/26
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific SessionsGlobeNewsWire • 06/03/26
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/28/26
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor ConferenceGlobeNewsWire • 05/12/26